mayo.edu Background Inherited polyneuropathies often go undiagnosed. We investigated whole exome sequencing (WES) in utility to identify the genetic causes of diverse forms of inherited ...

The "Whole Genome and Exome Sequencing Market: By Application, Organism and Product with Executive and Consultant Guid ...

The company will be the first to integrate whole genome sequencing (WGS) into Epic's Aura platform, further advancing access ...

To optimise FA patients’ characterisation, we developed a simplified but effective methodology based on whole exome sequencing (WES) and functional studies. Methods 68 patients with FA were analysed ...

NEW YORK – After two years of decline in 2022 and 2023, the 360Dx Top 30 rebounded in 2024, rising 4 percent year over year.

GeneDx Corp's 2024 success story: profitability, 100x returns, NICU market expansion, pediatric neurology diagnostics, and ...

The firms will combine Caris' multimodal genomic data with Ontada's community oncology-based real-world data to support cancer drug development.